Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Judith Ann Ferry, M.D.

Co-Author

This page shows the publications co-authored by Judith Ferry and Lyn Duncan.
Connection Strength

0.530
  1. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates. J Cutan Pathol. 2015 Jul; 42(7):452-8.
    View in: PubMed
    Score: 0.155
  2. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia. J Cutan Pathol. 2015 Jan; 42(1):6-15.
    View in: PubMed
    Score: 0.150
  3. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol. 2001 Jun; 25(6):732-41.
    View in: PubMed
    Score: 0.059
  4. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol. 1999 Jan; 23(1):88-96.
    View in: PubMed
    Score: 0.050
  5. IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study. Appl Immunohistochem Mol Morphol. 2018 08; 26(7):462-467.
    View in: PubMed
    Score: 0.048
  6. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol. 1996 Aug; 20(8):1011-23.
    View in: PubMed
    Score: 0.042
  7. Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med. 2009 Dec; 133(12):1949-53.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.